Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.

Heterocyclic-2-carboxylic acid (3-cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs.

Neglected diseases represent a major health problem. It is estimated that one third of the world population is infected with tuberculosis (TB). Besides TB, Chagas disease, affects approximately 20 million people. Quinoxalines display great activities against TB and Chagas. Forty new quinoxaline 1...

ver descrição completa

Detalhes bibliográficos
Principais autores: Ancizu, S. (Saioa), Moreno-de-Viguri, E. (Elsa), Torres, E. (Enrique), Burguete, A. (Asunción), Pérez-Silanes, S. (Silvia), Benitez, D. (Diego), Raquel, Solano, B. (Beatriz), Marin, A. (Adoración), Aldana, I. (Ignacio), Cerecetto, H. (Hugo), Gonzalez, M. (Mercedes), Monge, A. (Antonio)
Formato: info:eu-repo/semantics/article
Idioma:eng
Publicado em: MDPI 2012
Assuntos:
Quinoxaline
Neglected diseases
Mycobacterium tuberculosis
Trypanosoma cruz
Acesso em linha:https://hdl.handle.net/10171/23599

Internet

https://hdl.handle.net/10171/23599

Registros relacionados